Cromwell Holdings LLC Investment Activity Analysis for Q2 2026

As part of its ongoing investment strategy, Cromwell Holdings Llc has made several notable adjustments to its portfolio during the period ending June 30, 2026. These changes reflect shifts across various sectors and include both new positions and modifications to existing holdings.

Prominent New Vanguard Fund Acquisitions

Cromwell Holdings Llc significantly bolstered its exposure to broad-based index funds during Q2 2026, establishing or substantially increasing positions in three Vanguard exchange-traded funds (ETFs). The most substantial new position is Vanguard Tax-Managed Dividend Income ETF (VEA), representing approximately 0.57% of the portfolio, with a 100% increase in shares from the previous quarter.

• Purchase: The fund also initiated or dramatically increased its position in Vanguard Index Fund ETFs (VTI), allocating about 1.23% to this holding, which saw a 100% share increase.
• Purchase: Similarly, the position in iShares Core S&P Total U.S. Stock Market ETF (IVV) grew substantially by 100%, now comprising roughly 2.27% of Cromwell Holdings' portfolio.

These additions to the fund's holdings suggest a continued interest in diversified, market-tracking investments through exchange-traded instruments.

Increased Concentration in Specific Stocks

Beyond broad ETFs, Cromwell Holdings Llc also increased its stake in several individual stocks during this quarter. Notably, the fund purchased shares of Bank of America Corporation (BAC), adding about 0.5% to its allocation with a significant 45.7% increase in holdings.

• Purchase: The position in KLA Corporation (KLAC) also grew substantially, by an impressive 900%, adding another 0.56% to the portfolio.
• Purchase: Furthermore, the fund increased its stake in Nokia Corporation (NOK) by 33.47%, contributing 0.08% to the portfolio's weight.
• Purchase: The investment in Booking Holdings Inc. (BKNG) also saw a large boost, with a 2400% increase in shares adding 0.23%.

Strategic Reductions and Exits

In contrast to the aforementioned purchases, Cromwell Holdings Llc also reduced its positions in certain sectors or exited holdings entirely during Q2 2026.

• Sale/Reduction: The fund notably decreased its stake in Abbott Laboratories (ABT) by nearly half (-50.92%), reducing its allocation to 0.11%.
• Sale: It also sold shares of Medtronic PLC (MDT), completely exiting a position that previously held 0.05% of the portfolio.
• Exit: The fund exited its position in APO Pharmaceuticals Group Inc. (APO), which accounted for 0.03% previously, and also sold Delta Air Lines Corporation (DXCM) shares.

No Disclosures for Certain Activities

The provided data does not indicate any changes in holdings related to specific categories like significant sells of large-cap stocks outside the disclosed reductions, or detailed information on holdings within sectors such as Technology beyond what is listed.

Overall Portfolio Shifts

The observed activities this quarter show Cromwell Holdings Llc engaging in both strategic additions and reductions. The investor has shown a preference for broad-based ETFs, particularly those tracking the entire U.S. stock market or specific indices like VTI.

• Shift: There appears to be an increased focus on certain consumer cyclical stocks (like BKNG) alongside some notable exits from healthcare and other sectors.
• Trend: The fund's interest in Vanguard funds aligns with a trend towards tax-managed or broad market exposure, while the significant increase in shares for IVV points to continued confidence in total stock market representation.

For more detailed information on Cromwell Holdings Llc's portfolio and investment activities, please refer to their latest filing. Investors can explore holdings data at InsiderSet.